SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-082401
Filing Date
2004-05-10
Accepted
2004-05-07 19:24:54
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004 d10q.htm 10-Q 425478
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9860
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10579
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3262
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3280
  Complete submission text file 0001193125-04-082401.txt   454509
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26190 | Film No.: 04790701
SIC: 8093 Services-Specialty Outpatient Facilities, NEC